(ASRNL) ASR Nederland - Overview
Sector: Financial Services | Industry: Insurance - Diversified | Exchange: AS (Netherlands) | Market Cap: 13.588m EUR | Total Return: 24.7% in 12m
Avg Turnover: 31.3M
Warnings
No concerns identified
Tailwinds
Supp Ema20, Idiosyncratic Leader
ASR Nederland N.V. is a Dutch financial services provider specializing in insurance, pensions, and mortgages. The company operates across five primary segments: Non-Life, Life, Asset Management, Distribution and Services, and Holding and Other. Its portfolio includes disability, property and casualty, health, and funeral insurance, alongside pension products and individual term life policies.
The business model relies on a multi-brand strategy, utilizing names such as a.s.r. and Aegon to penetrate the residential mortgage market. As a multi-line insurer, ASR Nederland benefits from diversified revenue streams, balancing the shorter-term underwriting cycles of non-life products with the long-term capital management requirements of life and pension segments. The company also manages an extensive real estate and renewable energy asset portfolio, including wind and solar farms.
Historical data and valuation metrics on ValueRay can help clarify how these segments contribute to long-term growth. Founded in 1720 and headquartered in Utrecht, the firm maintains a significant presence in the Dutch domestic market through both direct services and specialized advisory brands focused on occupational health and reintegration.
- Integration of Aegon Netherlands assets accelerates cost synergies and market share growth
- Solvency II ratio fluctuations impact capital return and dividend payout sustainability
- Dutch mortgage market volatility influences asset management fees and interest margins
- Regulatory shifts in pension reform affect long-term life insurance liability management
- Rising claims inflation in non-life segments pressures technical margins and pricing power
| Net Income: 1.47b TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.01 > 0.02 and ΔFCF/TA -4.45 > 1.0 |
| NWC/Revenue: -43.38% < 20% (prev 16.85%; Δ -60.23% < -1%) |
| CFO/TA -0.01 > 3% & CFO -1.27b > Net Income 1.47b |
| Net Debt (7.83b) to EBITDA (18.5b): 0.42 < 3 |
| Current Ratio: 0.19 > 1.5 & < 3 |
| Outstanding Shares: last quarter (207.5m) vs 12m ago -11.93% < -2% |
| Gross Margin: error (current vs previous; cannot be calculated due to missing/invalid data or negative margin) |
| Asset Turnover: 20.56% > 50% (prev 13.01%; Δ 7.55% > 0%) |
| Interest Coverage Ratio: 1.85 > 6 (EBITDA TTM 18.5b / Interest Expense TTM 9.88b) |
| A: -0.09 (Total Current Assets 3.06b - Total Current Liabilities 16.1b) / Total Assets 142b |
| B: 0.03 (Retained Earnings 4.34b / Total Assets 142b) |
| C: 0.12 (EBIT TTM 18.3b / Avg Total Assets 146b) |
| D: 0.04 (Book Value of Equity 4.82b / Total Liabilities 134b) |
| Altman-Z'' = 0.37 = B |
| DSRI: 13.45 (Receivables 351.0m/17.0m, Revenue 30.1b/19.6b) |
| GMI: 0.89 (GM 111.7% / 99.87%) |
| AQI: 1.06 (AQ_t 0.97 / AQ_t-1 0.92) |
| SGI: 1.54 (Revenue 30.1b / 19.6b) |
| TATA: 0.02 (NI 1.47b - CFO -1.27b) / TA 142b) |
| Beneish M = 7.56 (Cap -4..+1) = D |
As of May 27, 2026, the stock is trading at EUR 66.46 with a total of 333,234 shares traded.
Over the past week, the price has changed by +3.51%,
over one month by +7.26%,
over three months by +10.12% and
over the past year by +24.73%.
ASR Nederland has no consensus analysts rating.
P/E Trailing = 30.4444
P/E Forward = 11.2613
P/S = 0.7935
P/B = 1.3579
Revenue TTM = 30.1b EUR
EBIT TTM = 18.3b EUR
EBITDA TTM = 18.5b EUR
Long Term Debt = 8.91b EUR (from longTermDebt, last quarter)
Short Term Debt = 70.0m EUR (from shortTermDebt, last fiscal year)
Debt = 10.5b EUR (from shortLongTermDebtTotal, last quarter) + Leases 120.0m
Net Debt = 7.83b EUR (calculated: Debt 10.5b - CCE 2.71b)
Enterprise Value = 21.4b EUR (13.6b + Debt 10.5b - CCE 2.71b)
Interest Coverage Ratio = 1.85 (Ebit TTM 18.3b / Interest Expense TTM 9.88b)
EV/FCF = -16.34x (Enterprise Value 21.4b / FCF TTM -1.31b)
FCF Yield = -6.12% (FCF TTM -1.31b / Enterprise Value 21.4b)
FCF Margin = -4.35% (FCF TTM -1.31b / Revenue TTM 30.1b)
Net Margin = 4.87% (Net Income TTM 1.47b / Revenue TTM 30.1b)
Gross Margin = unknown ((Revenue TTM 30.1b - Cost of Revenue TTM -3.52b) / Revenue TTM)
Tobins Q-Ratio = 0.15 (Enterprise Value 21.4b / Total Assets 142b)
Interest Expense / Debt = 93.77% (Interest Expense 9.88b / Debt 10.5b)
Taxrate = 18.18% (96.0m / 528.0m)
NOPAT = 15.0b (EBIT 18.3b * (1 - 18.18%))
Current Ratio = 0.19 (Total Current Assets 3.06b / Total Current Liabilities 16.1b)
Debt / Equity = 1.23 (Debt 10.5b / totalStockholderEquity, last quarter 8.60b)
Debt / EBITDA = 0.42 (Net Debt 7.83b / EBITDA 18.5b)
Debt / FCF = -5.97 (negative FCF - burning cash) (Net Debt 7.83b / FCF TTM -1.31b)
Total Stockholder Equity = 9.37b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.00% (Net Income 1.47b / Total Assets 142b)
RoE = 15.64% (Net Income TTM 1.47b / Total Stockholder Equity 9.37b)
RoCE = 100.1% (EBIT 18.3b / Capital Employed (Equity 9.37b + L.T.Debt 8.91b))
RoIC = 12.06% (NOPAT 15.0b / Invested Capital 124b)
WACC = 3.89% (E(13.6b)/V(24.1b) * Re(6.90%) + (debt cost/tax rate unavailable))
Discount Rate = 6.90% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 46.00 | Cagr: 19.53%
[DCF] Fair Price = unknown (Cash Flow -1.31b)
EPS Correlation: -60.73 | EPS CAGR: -24.20% | SUE: N/A | # QB: 0
Revenue Correlation: 91.10 | Revenue CAGR: 29.92% | SUE: 0.88 | # QB: 1
EPS current Year (2026-12-31): EPS=6.09 | Chg30d=+0.00% | Revisions=-20% | GrowthEPS=-4.2% | GrowthRev=+18.7%
EPS next Year (2027-12-31): EPS=6.24 | Chg30d=+0.00% | Revisions=+20% | GrowthEPS=+2.6% | GrowthRev=-7.3%
[Analyst] Revisions Ratio: -20%